The effects of anorexic drugs on free-fed rats responding under a second-order FI15-min (FR10:S) schedule for high incentive foods

Behavioural Pharmacology

Volumn 18, Issue 1, 2007, Pages 61-69

  Evenden, John ^a   Ko, Tracey ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Amphetamine; Fenfluramine; Motivation; Naloxone; Obesity; Rat

Indexed keywords

AMPHETAMINE; ANOREXIGENIC AGENT; DEXAMPHETAMINE; FENFLURAMINE; NALOXONE; RIMONABANT;

ANIMAL EXPERIMENT; ARTICLE; CACAO; CHEESE; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; FEEDING; FOOD; FOOD INTAKE; MALE; NONHUMAN; RAT; REINFORCEMENT;

ANIMALS; APPETITE; APPETITE DEPRESSANTS; APPETITIVE BEHAVIOR; BODY WEIGHT; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY INTAKE; EXTINCTION, PSYCHOLOGICAL; FEEDING BEHAVIOR; FENFLURAMINE; MALE; MOTIVATION; NALOXONE; PIPERIDINES; PYRAZOLES; RATS; RATS, LONG-EVANS; REINFORCEMENT SCHEDULE;

EID: 33846193735     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32801456c6     Document Type: Article

References (26)

1. Alderson HL, Robbins TW, Everitt BJ (2000). Heroin self-administration under a second-order schedule of reinforcement: acquisition and maintenance of heroin-seeking behaviour in rats. Psychopharmacology 153:120-133.
2. Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P, Le Fur G (1997). Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 132:104-106.
3. Arroyo M, Markou A, Robbins TW, Everitt BJ (1998). Acquisition, maintenance and reinstatement of intravenous cocaine self-administration under a second-order schedule of reinforcement in rats: effects of conditioned cues and continuous access to cocaine. Psychopharmacology 140:331-344.
4. Bays HE (2004). Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes Res 12:1187-1211.
5. Blundell JE, Finlayson G (2004). Is susceptibility to weight gain characterised by homeostatic or hedonic risk factors for overconsumption. Physiol Behav 82:21-25.
6. Blundell JE, Hill AJ (1987). Serotoninergic modulation of the pattern of eating and the profile of hunger-satiety in humans. Int J Obes 11:141-153.
7. Corrigall WA, Coen KM (1989). Fixed-interval schedules for drug self-administration in the rat. Psychopharmacology 99:136-139.
8. Epstein LH, Leddy JJ (2006). Food reinforcement. Appetite 46:22-25.
9. Everitt BJ, Dickinson A, Robbins TW (2001). The neuropsychological basis of addictive behaviour. Brain Res Brain Res Rev 36:129-138.
10. Fantino M, Hosette J, Apfelbaum M (1986). An opioid antagonist, naltrexone, reduces preference for sucrose in humans. Am J Physiol 251:R91-R96.
11. Foltin RW, Schuster CR (1983). Interaction between the effects of intragastric meals and drugs on feeding in rhesus monkeys. J Pharm Exp Ther 226:405-410.
12. Freedland CS, Poston LS, Porrino LJ (2000). Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding. Pharmacol Biochem Behav 67:265-270.
13. Glass MJ, O'Hare E, Cleary JP, Billington CJ, Levine AS (1999). The effect of naloxone on food-motivated behavior in the obese Zucker rat. Psychopharmacology 141:378-384.
14. Kirkham TC, Cooper SL (1988). Naloxone attenuation of sham feeding is modified by manipulation of sucrose concentration. Physiol Behav 44:491-494.
15. Le Merrer J, Stephens DN (2006). Food-induced behavior sensitization, its cross-sensitization to cocaine and morphine, pharmacological blockade and effect on food intake. J Neurosci 26:7163-7171.
16. LeSage MG, Stafford D, Glowa JR (2004). Effects of anorectic drugs on food intake under progressive ratio and free access conditions in rats. J Exp Anal Behav 82:275-292.
17. Morley JE, Levine AS, Yim GK, Lowy MT (1983). Opioid modulation of appetite. Neurosci Biobehav Rev 7:281-305.
18. National Research Council (1996). Animal environment, housing and management, p24. In: Guide for the care and use of laboratory animals. Grossblatt N, ed., Washington (DC): National Academy Press.
19. Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J, RIO-North America Study Group (2006). Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295:761-775.
20. Robbins TW (1981). Behavioural determinants of drug action: rate-dependency revisited. In: Cooper SJ, editor. Theory in psychopharmacology, Vol. 1. London: Academic Press. pp. 1-63.
21. Robinson TE, Berridge KC (1993). The neural basis of drug craving: an incentive-sensitization theory of addicition. Brain Res Rev 18:247-291.
22. Schindler CW, Panlilio LV, Goldberg SR (2002). Second-order schedules of drug self-administration in animals. Psychopharmacology 163:327-344.
23. Thornton-Jones ZD, Vickers SP, Clifton PG (2005). The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food. Psychopharmacology 179:452-460.
24. Volkow ND, Wise RA (2005). How can drug addiction help us understand obesity? Nat Neurosci 8:555-560.
25. Wadman M (2006). Rimonabant adds appetizing choice to slim obesity market. Nature Medicine 12:27.
26. 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71:341-348.